These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 31357652)

  • 1. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.
    Raaijmakers RHL; Ripken L; Ausems CRM; Wansink DG
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Induced (CTG⋅CAG)
    van Agtmaal EL; André LM; Willemse M; Cumming SA; van Kessel IDG; van den Broek WJAA; Gourdon G; Furling D; Mouly V; Monckton DG; Wansink DG; Wieringa B
    Mol Ther; 2017 Jan; 25(1):24-43. PubMed ID: 28129118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
    Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
    Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
    Wang Y; Hao L; Wang H; Santostefano K; Thapa A; Cleary J; Li H; Guo X; Terada N; Ashizawa T; Xia G
    Mol Ther; 2018 Nov; 26(11):2617-2630. PubMed ID: 30274788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.
    Lo Scrudato M; Poulard K; Sourd C; Tomé S; Klein AF; Corre G; Huguet A; Furling D; Gourdon G; Buj-Bello A
    Mol Ther; 2019 Aug; 27(8):1372-1388. PubMed ID: 31253581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
    André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.
    Dastidar S; Majumdar D; Tipanee J; Singh K; Klein AF; Furling D; Chuah MK; VandenDriessche T
    Mol Ther; 2022 Jan; 30(1):75-91. PubMed ID: 34371182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat.
    Gudde AEEG; van Heeringen SJ; de Oude AI; van Kessel IDG; Estabrook J; Wang ET; Wieringa B; Wansink DG
    RNA Biol; 2017 Oct; 14(10):1374-1388. PubMed ID: 28102759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.
    Izzo M; Battistini J; Provenzano C; Martelli F; Cardinali B; Falcone G
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.
    de Pontual L; Tomé S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.
    Batra R; Nelles DA; Roth DM; Krach F; Nutter CA; Tadokoro T; Thomas JD; Sznajder ŁJ; Blue SM; Gutierrez HL; Liu P; Aigner S; Platoshyn O; Miyanohara A; Marsala M; Swanson MS; Yeo GW
    Nat Biomed Eng; 2021 Feb; 5(2):157-168. PubMed ID: 32929188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9.
    Pinto BS; Saxena T; Oliveira R; Méndez-Gómez HR; Cleary JD; Denes LT; McConnell O; Arboleda J; Xia G; Swanson MS; Wang ET
    Mol Cell; 2017 Nov; 68(3):479-490.e5. PubMed ID: 29056323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.
    Gao Z; Cooper TA
    Hum Gene Ther; 2013 May; 24(5):499-507. PubMed ID: 23252746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual association of a unique CAG interruption in 5' of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism.
    Tomé S; Dandelot E; Dogan C; Bertrand A; Geneviève D; Péréon Y; ; Simon M; Bonnefont JP; Bassez G; Gourdon G
    Hum Mutat; 2018 Jul; 39(7):970-982. PubMed ID: 29664219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients.
    Braida C; Stefanatos RK; Adam B; Mahajan N; Smeets HJ; Niel F; Goizet C; Arveiler B; Koenig M; Lagier-Tourenne C; Mandel JL; Faber CG; de Die-Smulders CE; Spaans F; Monckton DG
    Hum Mol Genet; 2010 Apr; 19(8):1399-412. PubMed ID: 20080938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Diagnosis of Myotonic Dystrophy.
    Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
    Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides.
    Nakamori M; Gourdon G; Thornton CA
    Mol Ther; 2011 Dec; 19(12):2222-7. PubMed ID: 21971425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.